Toll Free: 1-888-928-9744
Published: Jul, 2014 | Pages:
37 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Serum Institute of India Limited - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Serum Institute of India Limited - Product Pipeline Review - 2014', provides an overview of the Serum Institute of India Limited's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Serum Institute of India Limited's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Serum Institute of India Limited including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Serum Institute of India Limited's human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Serum Institute of India Limited's pipeline products Reasons to buy - Evaluate Serum Institute of India Limited's strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Serum Institute of India Limited in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Serum Institute of India Limited's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Serum Institute of India Limited and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Serum Institute of India Limited - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Serum Institute of India Limited and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Serum Institute of India Limited Snapshot 5 Serum Institute of India Limited Overview 5 Key Information 5 Key Facts 5 Serum Institute of India Limited - Research and Development Overview 6 Key Therapeutic Areas 6 Serum Institute of India Limited - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Partnered Products 10 Partnered Products/Combination Treatment Modalities 11 Serum Institute of India Limited - Pipeline Products Glance 12 Serum Institute of India Limited - Late Stage Pipeline Products 12 Phase III Products/Combination Treatment Modalities 12 Serum Institute of India Limited - Clinical Stage Pipeline Products 13 Phase II Products/Combination Treatment Modalities 13 Phase I Products/Combination Treatment Modalities 14 Serum Institute of India Limited - Early Stage Pipeline Products 15 Preclinical Products/Combination Treatment Modalities 15 Discovery Products/Combination Treatment Modalities 16 Serum Institute of India Limited - Unknown Stage Pipeline Products 17 Unknown Products/Combination Treatment Modalities 17 Serum Institute of India Limited - Drug Profiles 18 Rotavirus Vaccine 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 ErepoXen 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 Measles Vaccine 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 SIILPCV-10 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 Conjugate Vaccine for Meningitis 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 DTaP Vaccine 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 Bladder Cancer Vaccine 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 pneumococcal polysaccharide conjugate vaccine 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 Serum Institute of India Limited - Pipeline Analysis 27 Serum Institute of India Limited - Pipeline Products by Target 27 Serum Institute of India Limited - Pipeline Products by Route of Administration 28 Serum Institute of India Limited - Pipeline Products by Molecule Type 29 Serum Institute of India Limited - Pipeline Products by Mechanism of Action 30 Serum Institute of India Limited - Recent Pipeline Updates 31 Serum Institute of India Limited - Dormant Projects 33 Serum Institute of India Limited - Locations And Subsidiaries 34 Head Office 34 Other Locations & Subsidiaries 34 Appendix 36 Methodology 36 Coverage 36 Secondary Research 36 Primary Research 36 Expert Panel Validation 36 Contact Us 37 Disclaimer 37
List of Tables Serum Institute of India Limited, Key Information 5 Serum Institute of India Limited, Key Facts 5 Serum Institute of India Limited - Pipeline by Indication, 2014 7 Serum Institute of India Limited - Pipeline by Stage of Development, 2014 8 Serum Institute of India Limited - Monotherapy Products in Pipeline, 2014 9 Serum Institute of India Limited - Partnered Products in Pipeline, 2014 10 Serum Institute of India Limited - Partnered Products/ Combination Treatment Modalities, 2014 11 Serum Institute of India Limited - Phase III, 2014 12 Serum Institute of India Limited - Phase II, 2014 13 Serum Institute of India Limited - Phase I, 2014 14 Serum Institute of India Limited - Preclinical, 2014 15 Serum Institute of India Limited - Discovery, 2014 16 Serum Institute of India Limited - Unknown, 2014 17 Serum Institute of India Limited - Pipeline by Target, 2014 27 Serum Institute of India Limited - Pipeline by Route of Administration, 2014 28 Serum Institute of India Limited - Pipeline by Molecule Type, 2014 29 Serum Institute of India Limited - Pipeline Products by Mechanism of Action, 2014 30 Serum Institute of India Limited - Recent Pipeline Updates, 2014 31 Serum Institute of India Limited - Dormant Developmental Projects,2014 33 Serum Institute of India Limited, Other Locations 34
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.